Management of haemophilia in three premature infants [2]

Haemophilia

Volumn 14, Issue 2, 2008, Pages 378-380

  Kraft, K E ^a   Verlaak, R ^b   Van Heijst, A F J ^a   Novakova I ^a   Brons, P P T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; D DIMER; FIBRINOGEN; HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9;

ANEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CASE REPORT; DEATH; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; ECHOGRAPHY; FIBRINOGEN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INFANT; LETTER; LUNG HEMORRHAGE; MALE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PREMATURITY; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; SEPSIS; THROMBOCYTE COUNT; TREATMENT DURATION;

DISEASES IN TWINS; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMOSTATICS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PREGNANCY;

EID: 40349108705     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01645.x     Document Type: Letter

References (5)

1. Gale RF, Hird MF, Colvin BT. Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia 1998; 4: 850-3.
2. Bidlingmaier C, Bergmann F, Kurnik K. Haemophilia A in two premature infants. Eur J Pediatr 2005; 164: 70-2.
3. Kulkarni L, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: A review of the literature. J Pediatr Haematol Oncol 1999; 21: 289-95.
4. Roth DA, Kessler CM, Pasi KJ, Rup B, Courter SG, Tubridy KL. Humam recombinant factor IX: Safety and efficacy studies in Hemophilia B patients previously treated with plasma-derived factor IX concentrates. Blood 2001; 98: 3600-6.
5. Gouw SC, van der Born JG, van den Berg HM. Treatment related risk factors of inhibitor development in previously untreated patients with hemophilia A: The CANAL cohort study. Blood 2007; 109: 4648-54.